Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial

Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new page revision indicator was added (v3.7.0) and the previous revision indicator (v3.6.6) was removed, signaling an internal update to the site's versioning. There is no change to the actual study data or user-facing content.
    Difference
    0.2%
    Check dated 2026-09-16T22:11:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    There are no additions or deletions provided in the input; the change set is empty. As a result, the page content remains unchanged according to the supplied data.
    Difference
    0.1%
    Check dated 2026-09-09T23:05:10.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    - Revision updated from v3.6.5 to v3.6.6. This is a minor metadata update and does not modify the study information or visible content.
    Difference
    0.2%
    Check dated 2026-09-02T20:59:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    No textual changes are recorded for this page in the provided data.
    Difference
    0.2%
    Check dated 2026-08-26T19:46:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    No additions or deletions were reported in the provided changes, so the page content remains unchanged. The page describes the Study Details for NCT04548791, a Phase 1/2 trial of Marzeptacog Alfa (Activated) in inherited bleeding disorders.
    Difference
    0.2%
    Check dated 2026-08-19T13:26:21.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from Revision: v3.6.4 to Revision: v3.6.5, representing a software version update. This change updates the site's metadata without altering the study details or content.
    Difference
    0.1%
    Check dated 2026-08-12T09:13:19.000Z thumbnail image

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.